CN116514703A - Method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone - Google Patents
Method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone Download PDFInfo
- Publication number
- CN116514703A CN116514703A CN202310130932.7A CN202310130932A CN116514703A CN 116514703 A CN116514703 A CN 116514703A CN 202310130932 A CN202310130932 A CN 202310130932A CN 116514703 A CN116514703 A CN 116514703A
- Authority
- CN
- China
- Prior art keywords
- butoxycarbonyl
- tert
- piperidone
- reductive amination
- dimethylaminopiperidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 N-tert-butoxycarbonyl-4-dimethylaminopiperidone Chemical compound 0.000 title claims abstract description 59
- ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 238000006268 reductive amination reaction Methods 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 57
- 239000002994 raw material Substances 0.000 claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 29
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 239000003054 catalyst Substances 0.000 claims abstract description 23
- 239000007787 solid Substances 0.000 claims abstract description 19
- OYEVFSJZQTUDDN-UHFFFAOYSA-N methanol;n-methylmethanamine Chemical compound OC.CNC OYEVFSJZQTUDDN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 12
- 230000002829 reductive effect Effects 0.000 claims abstract description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 8
- 239000001257 hydrogen Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000011068 loading method Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- DQXXKLYTOYMITI-UHFFFAOYSA-N 1-(dimethylamino)piperidin-2-one Chemical compound CN(C)N1CCCCC1=O DQXXKLYTOYMITI-UHFFFAOYSA-N 0.000 claims description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 2
- 229910052762 osmium Inorganic materials 0.000 claims description 2
- 238000005086 pumping Methods 0.000 claims description 2
- 229910052741 iridium Inorganic materials 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 239000002699 waste material Substances 0.000 abstract description 6
- 230000036632 reaction speed Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 22
- 239000000243 solution Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 7
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DOMCYLWSTZEWTQ-UHFFFAOYSA-N tert-butyl 4-(dimethylamino)piperidine-1-carboxylate Chemical compound CN(C)C1CCN(C(=O)OC(C)(C)C)CC1 DOMCYLWSTZEWTQ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
本申请涉及还原胺化方法领域,具体公开了一种还原胺化N‑叔丁氧羰基‑4‑哌啶酮的方法及N‑叔丁氧羰基‑4‑二甲氨基哌啶酮。本申请的方法,包括以下步骤:步骤S1,将有机溶剂、N‑叔丁氧羰基‑4‑哌啶酮与二甲胺甲醇混合得到原料液;并将催化剂装填至固定氢化床中;步骤S2,将原料液泵入固定氢化床中反应,压力2‑2.5MPa,温度50‑100℃,原料流速0.1‑1.6L/min,氢气流速,5‑30L/min,得到氢化液;步骤S3,将氢化液减压浓缩至固体析出;步骤S4:然后与乙醇混合,并将乙醇加热蒸除,得到产物。本申请的还原胺化N‑叔丁氧羰基‑4‑哌啶酮的方法具有步骤精简,有害废料较少,反应速度快,一次反应量大的效果。The application relates to the field of reductive amination methods, and specifically discloses a method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone. The method of the present application comprises the following steps: step S1, mixing the organic solvent, N-tert-butoxycarbonyl-4-piperidone and dimethylamine methanol to obtain a raw material liquid; and loading the catalyst into a fixed hydrogenation bed; step S2 , the raw material liquid is pumped into a fixed hydrogenation bed to react, the pressure is 2-2.5MPa, the temperature is 50-100°C, the raw material flow rate is 0.1-1.6L/min, the hydrogen flow rate is 5-30L/min, and the hydrogenated liquid is obtained; step S3, the The hydrogenation solution is concentrated under reduced pressure until solids are precipitated; step S4: then mixed with ethanol, and the ethanol is heated and evaporated to obtain the product. The method for reductive amination of N-tert-butoxycarbonyl-4-piperidone of the present application has the effects of simplified steps, less harmful waste, fast reaction speed and large reaction volume at one time.
Description
技术领域technical field
本申请涉及还原胺化方法的领域,更具体地说,它涉及一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法及N-叔丁氧羰基-4-二甲氨基哌啶酮。This application relates to the field of reductive amination methods, more specifically, it relates to a method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperone pyridone.
背景技术Background technique
还原胺化反应,是一种简便的把醛酮转换成胺的方法;N-叔丁氧羰基-4-哌啶酮是一种用途广泛的医药中间体,通常将N-叔丁氧羰基-4-哌啶酮还原胺化后,才能进行下一步药物的合成。Reductive amination reaction is a simple method to convert aldehydes and ketones into amines; N-tert-butoxycarbonyl-4-piperidone is a widely used pharmaceutical intermediate, usually N-tert-butoxycarbonyl- After the reductive amination of 4-piperidone, the next step of drug synthesis can be carried out.
相关技术中,氰基硼氰钠与三乙酰氧基硼氢钠是近年开发的一种新的具有较好普适性和选择性的还原胺化试剂,三乙酰氧基硼氢钠的英文缩写为STAB-H,由硼氢化钠和乙酸在苯或N,N-二甲基乙酰胺中制得。STAB-H还原胺化反应条件温和,催化还原性能好,且易于分离纯化,催化剂本身和副产物都无毒,对环境没有污染,由于STAB-H结构中只有一个氢负离子,因此用量可以得到相对严格的控制,成为还原胺化反应首选的催化剂。三乙酰氧基硼氢钠还原胺化N-叔丁氧羰基-4-哌啶酮的化学方程式如下:In related technologies, sodium cyanoborocyanide and sodium triacetoxyborohydride are new reductive amination reagents developed in recent years with good universality and selectivity. The English abbreviation of sodium triacetoxyborohydride is For STAB-H, it is prepared by sodium borohydride and acetic acid in benzene or N,N-dimethylacetamide. The reductive amination reaction conditions of STAB-H are mild, the catalytic reduction performance is good, and it is easy to separate and purify. The catalyst itself and by-products are non-toxic, and there is no pollution to the environment. Since there is only one hydride ion in the STAB-H structure, the dosage can be obtained relatively Strict control makes it the preferred catalyst for reductive amination reaction. The chemical equation for the reductive amination of N-tert-butoxycarbonyl-4-piperidone by sodium triacetoxyborohydride is as follows:
三乙酰氧基硼氢钠还原胺化的工艺如下:1,将N-叔丁氧羰基-4-哌啶酮、三乙酰氧基硼氢化钠和四氢呋喃依次加入间歇釜,在10-25℃下保温加压反应;2,中控合格后,控温5-25℃,向体系中加水淬灭反应,搅拌;3,浓缩除去四氢呋喃;4,加水,溶解析出固体盐;5,将二氯甲烷加入固体盐,萃取5次;6,氯化钠水溶液洗涤有机相;7,无水硫酸镁除水,压滤;8,浓缩除溶剂至粘稠状;9,加入正庚烷打浆,离心;10,干燥。The reductive amination process of sodium triacetoxyborohydride is as follows: 1. Add N-tert-butoxycarbonyl-4-piperidone, sodium triacetoxyborohydride and tetrahydrofuran in sequence to a batch kettle, Insulation and pressure reaction; 2. After the central control is qualified, control the temperature at 5-25°C, add water to the system to quench the reaction, and stir; 3. Concentrate to remove tetrahydrofuran; 4. Add water to dissolve and separate out solid salt; 5. Dichloromethane Add solid salt and extract 5 times; 6. Wash the organic phase with aqueous sodium chloride solution; 7. Remove water with anhydrous magnesium sulfate and press filter; 8. Concentrate and remove solvent until viscous; 9. Add n-heptane for beating and centrifuge; 10. Dry.
上述中的相关技术使用三乙酰氧基硼氢化钠作为还原胺化试剂,反应完需要进行淬灭、浓缩、稀释、成盐、萃取、盐洗、脱溶等步骤,后处理繁琐,会产生大量的三废,存在污染严重的问题。The above-mentioned related technology uses sodium triacetoxyborohydride as a reductive amination reagent. After the reaction, steps such as quenching, concentration, dilution, salt formation, extraction, salt washing, and solvent removal are required. The post-treatment is cumbersome and will generate a large amount of The three wastes have serious pollution problems.
发明内容Contents of the invention
为了精简N-叔丁氧羰基-4-哌啶酮还原胺化的步骤,且减少三废的排放量,本申请提供一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法及N-叔丁氧羰基-4-二甲氨基哌啶酮。In order to simplify the steps of reductive amination of N-tert-butoxycarbonyl-4-piperidone and reduce the discharge of three wastes, the application provides a method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone.
第一方面,本申请提供的一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法,采用如下的技术方案:In the first aspect, a method for reductive amination of N-tert-butoxycarbonyl-4-piperidone provided by the present application adopts the following technical scheme:
一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法,包括以下步骤:A method for reductive amination of N-tert-butoxycarbonyl-4-piperidone, comprising the following steps:
步骤S1:将有机溶剂、N-叔丁氧羰基-4-哌啶酮与二甲胺甲醇混合得到原料液;并将催化剂装填至固定氢化床中;Step S1: mixing an organic solvent, N-tert-butoxycarbonyl-4-piperidone and dimethylamine methanol to obtain a raw material liquid; and loading the catalyst into a fixed hydrogenation bed;
步骤S2,将原料液泵入固定氢化床中反应,压力2-2.5MPa,温度50-100℃,原料流速0.1-1.6L/min,氢气流速,5-30L/min,得到氢化液;Step S2, pumping the raw material liquid into a fixed hydrogenation bed for reaction at a pressure of 2-2.5 MPa, a temperature of 50-100°C, a raw material flow rate of 0.1-1.6 L/min, and a hydrogen flow rate of 5-30 L/min to obtain a hydrogenated liquid;
步骤S3:将氢化液减压浓缩至固体析出,得到初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮;Step S3: concentrating the hydrogenation solution under reduced pressure until solids are precipitated to obtain the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone;
步骤S4:将初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇混合,并将乙醇加热蒸除,得到N-叔丁氧羰基-4-二甲氨基哌啶酮,即N-叔丁氧羰基-4-哌啶酮还原胺化的产物;还原胺化N-叔丁氧羰基-4-哌啶酮的化学方程式如下:Step S4: Mix the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone with ethanol, and heat and distill the ethanol to obtain N-tert-butoxycarbonyl-4-dimethylaminopiperidone, That is, the product of N-tert-butoxycarbonyl-4-piperidone reductive amination; the chemical equation of reductive amination N-tert-butoxycarbonyl-4-piperidone is as follows:
通过采用上述技术方案,使用固定床氢化技术进行N-叔丁氧羰基-4-哌啶酮的还原胺化反应,后处理步骤仅需要浓缩、乙醇带蒸两步,就能够得到纯度高达99.8%的N-叔丁氧羰基-4-二甲氨基哌啶酮,相比于传统的还原胺化方法,步骤精简,有害废料较少。By adopting the above technical scheme and using fixed-bed hydrogenation technology to carry out the reductive amination reaction of N-tert-butoxycarbonyl-4-piperidone, the post-treatment steps only need two steps of concentration and distillation with ethanol to obtain a purity as high as 99.8%. Compared with the traditional reductive amination method, the N-tert-butoxycarbonyl-4-dimethylaminopiperidone has simplified steps and fewer harmful wastes.
且上述反应在固定氢化床中进行,相比于传统的在间歇釜中进行的反应,不存在高压高温的安全问题,且一次的加料量远远大于间歇釜的加料量,安全、高效的绿色加氢技术具有加快反应速度,减小反应器体积,提高反应选择性,避免催化剂分离,提高安全性,连续自动化等优点,有望颠覆精细化学品粗放式的生产现状,实现生产技术的跨越式提升。And the above reaction is carried out in a fixed hydrogenation bed. Compared with the traditional reaction in a batch kettle, there is no safety problem of high pressure and high temperature, and the amount of feeding at one time is much larger than that of the batch kettle. It is a safe and efficient green Hydrogenation technology has the advantages of accelerating reaction speed, reducing reactor volume, improving reaction selectivity, avoiding catalyst separation, improving safety, and continuous automation. It is expected to overturn the current situation of extensive production of fine chemicals and achieve a leapfrog improvement in production technology .
可选的,所述原料液包括以下重量份的组分:9.5-11.5份有机溶剂,19-23份N-叔丁氧羰基-4-哌啶酮,0.9-1份二甲胺甲醇和0.01-0.03份催化剂。Optionally, the raw material liquid includes the following components in parts by weight: 9.5-11.5 parts of organic solvent, 19-23 parts of N-tert-butoxycarbonyl-4-piperidone, 0.9-1 part of dimethylamine methanol and 0.01 -0.03 part catalyst.
通过采用上述技术方案,有机溶剂用于将N-叔丁氧羰基-4-哌啶酮与二甲胺甲醇溶解,配置呈液体状,催化剂提前加入固定氢化床中,能够在反应全过程对原料液进行充分的催化;则反应液在氢化床中进行反应时,反应较彻底,使得最终制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率高达95.3%,纯度高达99.8%。By adopting the above technical scheme, the organic solvent is used to dissolve N-tert-butoxycarbonyl-4-piperidone and dimethylamine methanol, and the configuration is in a liquid state. The catalyst is added to the fixed hydrogenation bed in advance, and the raw materials can be treated during the whole reaction process. The liquid is fully catalyzed; when the reaction liquid is reacted in the hydrogenation bed, the reaction is relatively thorough, so that the yield of N-tert-butoxycarbonyl-4-dimethylaminopiperidone finally obtained is as high as 95.3%, and the purity is as high as 99.8% %.
可选的,所述催化剂为Pd/C、Pt/C、Rh/C、Ir/C、Ru/C或Os/C。Optionally, the catalyst is Pd/C, Pt/C, Rh/C, Ir/C, Ru/C or Os/C.
通过采用上述技术方案,上述催化剂均为常用的催化剂,价格低廉,容易获取,便于本申请的N-叔丁氧羰基-4-二甲氨基哌啶酮还原胺化方法在工业上推广应用。By adopting the above-mentioned technical scheme, the above-mentioned catalysts are commonly used catalysts, are cheap and easy to obtain, and facilitate the industrial application of the N-tert-butoxycarbonyl-4-dimethylaminopiperidone reductive amination method of the present application.
可选的,所述有机溶剂为甲醇、乙醇或异丙醇。Optionally, the organic solvent is methanol, ethanol or isopropanol.
通过采用上述技术方案,上述有机溶剂均为价格低廉,易于获取的有机溶剂,便于本申请的N-叔丁氧羰基-4-二甲氨基哌啶酮还原胺化方法在工业上推广应用。By adopting the above-mentioned technical scheme, the above-mentioned organic solvents are all cheap and easy to obtain organic solvents, which facilitates the industrial application of the N-tert-butoxycarbonyl-4-dimethylaminopiperidone reductive amination method of the present application.
可选的,所述步骤S1中,将有机溶剂、N-叔丁氧羰基-4-哌啶酮与二甲胺甲醇混合后,还包括过滤杂质的步骤,最终得到原料液。Optionally, in the step S1, after mixing the organic solvent, N-tert-butoxycarbonyl-4-piperidone and dimethylamine methanol, a step of filtering impurities is also included to finally obtain a raw material solution.
通过采用上述技术方案,过滤杂质的目的在于,将反应原料中的其他固体杂质过滤除去,使得反应原料纯净,制备得到的N-叔丁氧羰基-4-二甲氨基哌啶酮纯度高达99.8%。By adopting the above technical scheme, the purpose of filtering impurities is to filter out other solid impurities in the reaction raw materials, so that the reaction raw materials are pure, and the prepared N-tert-butoxycarbonyl-4-dimethylaminopiperidone has a purity of up to 99.8%. .
可选的,所述步骤S3中,将氢化液在50-60℃下,小于-70KPa的压力下,减压浓缩至固体析出,得到初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮。Optionally, in the step S3, the hydrogenation solution is concentrated under reduced pressure at a temperature of 50-60°C and a pressure less than -70KPa until solids are precipitated to obtain the initially treated N-tert-butoxycarbonyl-4-dimethylamino piperidone.
通过采用上述技术方案,在50-60℃下减压浓缩的目的在于,在不破坏初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮的前提下,加快减压浓缩的速度,提高整体反应速度。By adopting the above technical scheme, the purpose of concentrating under reduced pressure at 50-60°C is to speed up the speed of concentrating under reduced pressure without destroying the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone , to improve the overall response speed.
可选的,所述步骤S4中,初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇的体积比是1:(9-11)。Optionally, in the step S4, the volume ratio of the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone to ethanol is 1:(9-11).
通过采用上述技术方案,合适的初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇的配比,使得乙醇即不产生浪费,而且也能将初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮掺杂的杂质最大量的带走。By adopting the above-mentioned technical scheme, the proportioning of the N-tert-butoxycarbonyl-4-dimethylaminopiperidone and ethanol that is suitable for preliminary treatment makes ethanol not produce waste, and the N-tert-butyl Oxycarbonyl-4-dimethylaminopiperidone doped impurities were carried away in the greatest amount.
可选的,所述步骤S4中,加热蒸除乙醇的温度为50-60℃。Optionally, in the step S4, the temperature for distilling ethanol by heating is 50-60°C.
通过采用上述技术方案,加热蒸除乙醇,使得乙醇能带走除N-叔丁氧羰基-4-二甲氨基哌啶酮以外的其他物质速度更快,加快纯化N-叔丁氧羰基-4-二甲氨基哌啶酮的速度,加快整体反应效率。By adopting the above-mentioned technical scheme, heating and distilling ethanol, so that ethanol can take away other substances except N-tert-butoxycarbonyl-4-dimethylaminopiperidone faster, and speed up the purification of N-tert-butoxycarbonyl-4 - The speed of dimethylaminopiperidone, to speed up the overall reaction efficiency.
第二方面,本申请提供一种N-叔丁氧羰基-4-二甲氨基哌啶酮,采用如下的技术方案:一种N-叔丁氧羰基-4-二甲氨基哌啶酮由上述方法制备得到。In the second aspect, the application provides a kind of N-tert-butoxycarbonyl-4-dimethylaminopiperidone, which adopts the following technical scheme: a kind of N-tert-butoxycarbonyl-4-dimethylaminopiperidone is obtained by the above-mentioned method prepared.
通过采用上述技术方案,采用上述制备方法制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率为95.3%,纯度为99.8%,PMI为16.5,收率、纯度远远大于传统技术制备得到的N-叔丁氧羰基-4-二甲氨基哌啶酮的收率、纯度;PMI远远小于传统技术制备得到的N-叔丁氧羰基-4-二甲氨基哌啶酮的PMI;证明,本申请的制备方法能够生产出质量较好的N-叔丁氧羰基-4-二甲氨基哌啶酮。By adopting the above-mentioned technical scheme, the yield of N-tert-butoxycarbonyl-4-dimethylaminopiperidone obtained by the above-mentioned preparation method is 95.3%, the purity is 99.8%, and the PMI is 16.5. The yield and purity are far greater than The yield and purity of N-tert-butoxycarbonyl-4-dimethylaminopiperidone prepared by traditional technology; PMI is far less than that of N-tert-butoxycarbonyl-4-dimethylaminopiperidone prepared by traditional technology The PMI; Prove, the preparation method of the present application can produce the better quality N-tert-butoxycarbonyl-4-dimethylaminopiperidone.
综上所述,本申请具有以下有益效果:In summary, the application has the following beneficial effects:
1、本申请中,使用固定床氢化技术进行N-叔丁氧羰基-4-哌啶酮的还原胺化反应,后处理步骤仅需要浓缩、乙醇带蒸两步,就能够得到纯度高达99.8%的N-叔丁氧羰基-4-二甲氨基哌啶酮,相比于传统的还原胺化方法,步骤精简,有害废料较少,反应速度快,一次反应量大;2、本申请的还原胺化方法中,在50-60℃下减压浓缩的目的在于,在不破坏初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮的前提下,加快减压浓缩的速度,提高整体反应速度;1. In this application, the reductive amination reaction of N-tert-butoxycarbonyl-4-piperidone is carried out using fixed-bed hydrogenation technology. The post-processing steps only need two steps of concentration and ethanol steaming, and the purity can be as high as 99.8%. Compared with the traditional reductive amination method, the N-tert-butoxycarbonyl-4-dimethylaminopiperidone has simplified steps, less harmful waste, fast reaction speed and large reaction volume at one time; 2. The reduction method of the present application In the amination method, the purpose of concentrating under reduced pressure at 50-60°C is to speed up the concentration under reduced pressure without destroying the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone. Improve the overall response speed;
3、采用本申请的方法制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率为95.3%,纯度为99.8%,PMI为16.5,远远优于传统技术制备得到的N-叔丁氧羰基-4-二甲氨基哌啶酮的收率、纯度与PMI。3. The yield of N-tert-butoxycarbonyl-4-dimethylaminopiperidone prepared by the method of the present application is 95.3%, the purity is 99.8%, and the PMI is 16.5, which is far superior to the N-butoxycarbonyl-4-dimethylaminopiperidone prepared by traditional techniques. - Yield, purity and PMI of tert-butoxycarbonyl-4-dimethylaminopiperidone.
附图说明Description of drawings
图1是旨在显示实施例3制得的N-叔丁氧羰基-4-二甲氨基哌啶酮的液相色谱图。Figure 1 is intended to show the liquid chromatogram of N-tert-butoxycarbonyl-4-dimethylaminopiperidone prepared in Example 3.
具体实施方式Detailed ways
以下结合实施例与对比例对本申请作进一步详细说明。The present application will be described in further detail below in conjunction with examples and comparative examples.
提供以下实施例和对比例的原料来源:实施例与对比例的原料均可市售购得。The sources of raw materials for the following examples and comparative examples are provided: the raw materials for the examples and comparative examples are all commercially available.
一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法的实施例A kind of embodiment of the method of reductive amination N-tert-butoxycarbonyl-4-piperidone
实施例1Example 1
一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法,包括以下步骤:A method for reductive amination of N-tert-butoxycarbonyl-4-piperidone, comprising the following steps:
步骤S1:将9.5kg异丙醇、23kg N-叔丁氧羰基-4-哌啶酮、0.9kg二甲胺甲醇混合均匀,过滤除去固体杂质,得到原料液;然后将0.03kg催化剂Rh/C加入固定床催化剂;Step S1: Mix 9.5kg of isopropanol, 23kg of N-tert-butoxycarbonyl-4-piperidone, and 0.9kg of dimethylamine methanol, and filter to remove solid impurities to obtain a raw material solution; then 0.03kg of catalyst Rh/C Add fixed bed catalyst;
步骤S2:将原料液泵入固定氢化床中反应,设置压力2MPa,温度100℃,原料流速0.1L/min,氢气流速,30L/min,得到氢化液;Step S2: Pump the raw material liquid into the fixed hydrogenation bed for reaction, set the pressure at 2 MPa, the temperature at 100°C, the raw material flow rate at 0.1 L/min, and the hydrogen flow rate at 30 L/min to obtain the hydrogenated liquid;
步骤S3:将氢化液在50℃下,-60KPa的压力下,减压浓缩至固体析出,得到初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮;Step S3: Concentrate the hydrogenation solution under reduced pressure at 50°C and a pressure of -60KPa until solids are precipitated to obtain the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone;
步骤S4:将初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇混合,其中,初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇的体积比为1:9;然后将乙醇在50℃下加热蒸除,得到N-叔丁氧羰基-4-二甲氨基哌啶酮,即N-叔丁氧羰基-4-哌啶酮还原胺化的产物;还原胺化N-叔丁氧羰基-4-哌啶酮的化学方程式如下:Step S4: Mix the pre-treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone with ethanol, wherein the volume of the pre-treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone and ethanol The ratio is 1:9; then the ethanol is heated and distilled off at 50°C to obtain N-tert-butoxycarbonyl-4-dimethylaminopiperidone, that is, the reductive amination of N-tert-butoxycarbonyl-4-piperidone The product; The chemical equation of reductive amination N-tert-butoxycarbonyl-4-piperidone is as follows:
实施例2Example 2
一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法,包括以下步骤:A method for reductive amination of N-tert-butoxycarbonyl-4-piperidone, comprising the following steps:
步骤S1:将11.5kg乙醇、19kg N-叔丁氧羰基-4-哌啶酮、1kg二甲胺甲醇混合均匀,过滤除去固体杂质,得到原料液;然后将0.01kg催化剂Pt/C加入固定床催化剂;Step S1: Mix 11.5kg ethanol, 19kg N-tert-butoxycarbonyl-4-piperidone, and 1kg dimethylamine methanol evenly, filter to remove solid impurities, and obtain a raw material solution; then add 0.01kg catalyst Pt/C to the fixed bed catalyst;
步骤S2:将原料液泵入固定氢化床中反应,设置压力2.5MPa,温度50℃,原料流速1.6L/min,氢气流速,5L/min,得到氢化液;Step S2: Pump the raw material liquid into the fixed hydrogenation bed for reaction, set the pressure at 2.5MPa, the temperature at 50°C, the raw material flow rate at 1.6L/min, and the hydrogen flow rate at 5L/min to obtain the hydrogenated liquid;
步骤S3:将氢化液在60℃下,-40KPa的压力下,减压浓缩至固体析出,得到初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮;Step S3: Concentrate the hydrogenation solution under reduced pressure at 60°C and a pressure of -40KPa until solids are precipitated to obtain the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone;
步骤S4:将初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇混合,其中,初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇的体积比为1:11;然后将乙醇在60℃下加热蒸除,得到N-叔丁氧羰基-4-二甲氨基哌啶酮,即N-叔丁氧羰基-4-哌啶酮还原胺化的产物;还原胺化N-叔丁氧羰基-4-哌啶酮的化学方程式如下:Step S4: Mix the pre-treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone with ethanol, wherein the volume of the pre-treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone and ethanol The ratio is 1:11; then the ethanol is heated and distilled off at 60°C to obtain N-tert-butoxycarbonyl-4-dimethylaminopiperidone, that is, the reductive amination of N-tert-butoxycarbonyl-4-piperidone The product; The chemical equation of reductive amination N-tert-butoxycarbonyl-4-piperidone is as follows:
实施例3Example 3
一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法,包括以下步骤:A method for reductive amination of N-tert-butoxycarbonyl-4-piperidone, comprising the following steps:
步骤S1:将10.6kg甲醇、21kg N-叔丁氧羰基-4-哌啶酮、0.905kg二甲胺甲醇混合均匀,过滤除去固体杂质,得到原料液;然后将0.01kg催化剂Pd/C加入固定床催化剂;Step S1: Mix 10.6kg of methanol, 21kg of N-tert-butoxycarbonyl-4-piperidone, and 0.905kg of dimethylamine methanol, and filter to remove solid impurities to obtain a raw material solution; then add 0.01kg of catalyst Pd/C to fix bed catalyst;
步骤S2:将原料液泵入固定氢化床中反应,设置压力2.3MPa,温度70℃,原料流速1L/min,氢气流速,15L/min,得到氢化液;Step S2: Pump the raw material liquid into the fixed hydrogenation bed for reaction, set the pressure at 2.3MPa, temperature at 70°C, raw material flow rate at 1L/min, hydrogen flow rate at 15L/min, to obtain hydrogenated liquid;
步骤S3:将氢化液在55℃下,-60KPa的压力下,减压浓缩至固体析出,得到初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮;Step S3: Concentrate the hydrogenation solution under reduced pressure at 55°C and a pressure of -60KPa until solids are precipitated to obtain the initially treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone;
步骤S4:将初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇混合,其中,初处理的N-叔丁氧羰基-4-二甲氨基哌啶酮与乙醇的体积比为1:10.6;然后将乙醇在60℃下加热蒸除,得到N-叔丁氧羰基-4-二甲氨基哌啶酮,即N-叔丁氧羰基-4-哌啶酮还原胺化的产物;还原胺化N-叔丁氧羰基-4-哌啶酮的化学方程式如下:Step S4: Mix the pre-treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone with ethanol, wherein the volume of the pre-treated N-tert-butoxycarbonyl-4-dimethylaminopiperidone and ethanol The ratio is 1:10.6; then the ethanol is heated and evaporated at 60°C to obtain N-tert-butoxycarbonyl-4-dimethylaminopiperidone, that is, the reductive amination of N-tert-butoxycarbonyl-4-piperidone The product; The chemical equation of reductive amination N-tert-butoxycarbonyl-4-piperidone is as follows:
对比例1Comparative example 1
与实施例3的不同之处在于,步骤S2不同,具体步骤如下;The difference from embodiment 3 is that step S2 is different, and the specific steps are as follows;
步骤S2:将原料液泵入固定氢化床中反应,设置压力5MPa,温度150℃,原料流速0.05L/min,氢气流速,50L/min,得到氢化液。Step S2: Pump the raw material liquid into the fixed hydrogenation bed for reaction, set the pressure at 5 MPa, the temperature at 150°C, the raw material flow rate at 0.05 L/min, and the hydrogen flow rate at 50 L/min to obtain hydrogenated liquid.
对比例2Comparative example 2
与实施例3的不同之处在于,步骤S2不同,具体步骤如下;The difference from embodiment 3 is that step S2 is different, and the specific steps are as follows;
步骤S2:将原料液泵入固定氢化床中反应,设置压力0.5MPa,温度30℃,原料流速5L/min,氢气流速,1L/min,得到氢化液。Step S2: Pump the raw material solution into the fixed hydrogenation bed for reaction, set the pressure at 0.5 MPa, the temperature at 30°C, the raw material flow rate at 5 L/min, and the hydrogen flow rate at 1 L/min to obtain a hydrogenated liquid.
对比例3Comparative example 3
与实施例3的不同之处在于,步骤S1不同,具体步骤如下;The difference from embodiment 3 is that step S1 is different, and the specific steps are as follows;
步骤S1:将20kg甲醇、12kg N-叔丁氧羰基-4-哌啶酮、3kg二甲胺甲醇混合均匀,过滤除去固体杂质,得到原料液;然后将0.005kg催化剂Pd/C加入固定床催化剂。Step S1: Mix 20kg of methanol, 12kg of N-tert-butoxycarbonyl-4-piperidone, and 3kg of dimethylamine methanol evenly, filter to remove solid impurities, and obtain a raw material solution; then add 0.005kg of catalyst Pd/C to the fixed-bed catalyst .
对比例4Comparative example 4
与实施例3的不同之处在于,步骤S1不同,具体步骤如下;The difference from embodiment 3 is that step S1 is different, and the specific steps are as follows;
步骤S1:将5kg甲醇、30kg N-叔丁氧羰基-4-哌啶酮、0.5kg二甲胺甲醇混合均匀,过滤除去固体杂质,得到原料液;然后将0.06kg催化剂Pd/C加入固定床催化剂。Step S1: Mix 5kg of methanol, 30kg of N-tert-butoxycarbonyl-4-piperidone, and 0.5kg of dimethylamine methanol, and filter to remove solid impurities to obtain a raw material solution; then add 0.06kg of catalyst Pd/C to the fixed bed catalyst.
对比例5Comparative example 5
一种还原胺化N-叔丁氧羰基-4-哌啶酮的方法,包括以下步骤:A method for reductive amination of N-tert-butoxycarbonyl-4-piperidone, comprising the following steps:
1,将21kg N-叔丁氧羰基-4-哌啶酮与21kg三乙酰氧基硼氢化钠、10.6kg四氢呋喃与0.0225kg浓度为12mol/L的盐酸依次加入间歇釜,在20℃下保温加压反应72h;2,控温20℃,向体系中加反应原料5倍体积的水淬灭反应,搅拌均匀;3,在55℃下,-60KPa的压力下,浓缩除去四氢呋喃;4,向3得到的产物中加入5倍体积的水,溶解析出固体盐;5,将二氯甲烷加入固体盐,萃取5次,得到有机相,二氯甲烷与固体盐的重量比为10:1;6,使用氯化钠水溶液洗涤有机相,有机相与氯化钠水溶液的体积比为1:2;7,使用3g无水硫酸镁除水,压滤;8,在55℃下,-60KPa的压力下浓缩除溶剂至粘稠状;9,加入正庚烷打浆,离心;10,干燥,得到N-叔丁氧羰基-4-二甲氨基哌啶酮。1. Add 21kg of N-tert-butoxycarbonyl-4-piperidone, 21kg of sodium triacetoxyborohydride, 10.6kg of tetrahydrofuran and 0.0225kg of hydrochloric acid with a concentration of 12mol/L into the batch kettle in sequence, and heat at 20°C. Pressure reaction for 72 hours; 2. Control the temperature at 20°C, add 5 times the volume of water to the system to quench the reaction, and stir evenly; 3. Concentrate and remove THF at 55°C and a pressure of -60KPa; 4. Add to 3 Add 5 times the volume of water to the obtained product to dissolve and separate the solid salt; 5. Add dichloromethane to the solid salt and extract 5 times to obtain an organic phase. The weight ratio of dichloromethane to solid salt is 10:1; 6. Use sodium chloride aqueous solution to wash the organic phase, the volume ratio of organic phase to sodium chloride aqueous solution is 1:2; 7, use 3g of anhydrous magnesium sulfate to remove water, press filter; 8, at 55°C, under the pressure of -60KPa Concentrate to remove the solvent until it becomes viscous; 9, add n-heptane to make a slurry, and centrifuge; 10, dry to obtain N-tert-butoxycarbonyl-4-dimethylaminopiperidone.
性能检测试验performance test
采用实施例1至3和对比例1至5中制得的N-叔丁氧羰基-4-二甲氨基哌啶酮进行性能测试,检测收率,纯度与PMI;The N-tert-butoxycarbonyl-4-dimethylaminopiperidone prepared in Examples 1 to 3 and Comparative Examples 1 to 5 was used for performance testing, detection yield, purity and PMI;
检测依据:收率=(反应产物/反应原料)×100%;Detection basis: yield=(reaction product/reaction raw material)×100%;
纯度用液相色谱检测:计算N-叔丁氧羰基-4-二甲氨基哌啶酮峰面积占总产物峰面积的百分比;Purity is detected by liquid chromatography: calculate the percentage of N-tert-butoxycarbonyl-4-dimethylaminopiperidone peak area in the total product peak area;
PMI:产品生产全过程中所有物质的质量总和与目标产物质量的比值;PMI: the ratio of the sum of the mass of all substances in the whole process of product production to the mass of the target product;
测试结果如表1所示;实施例3的产物液相色谱图也展示在说明书附图1中;The test results are shown in Table 1; the product liquid chromatogram of Example 3 is also shown in the accompanying drawing 1 of the description;
表1Table 1
结合实施例1、2和实施例3,可以看出,实施例1、2、3的反应条件与反应原料用量均不同,但是均在本申请的保护范围内,实施例1、2、3制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率与纯度均较高,PMI较低;且实施例3制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率与纯度最高,PMI最低;因此,实施例3的反应条件与原料用量最佳。In conjunction with embodiment 1,2 and embodiment 3, it can be seen that the reaction conditions and reaction raw material consumption of embodiment 1,2,3 are all different, but all within the protection scope of the application, embodiment 1,2,3 system The obtained N-tert-butoxycarbonyl-4-dimethylaminopiperidone yield and purity are higher, and the PMI is lower; and the N-tert-butoxycarbonyl-4-dimethylaminopiperidine obtained in Example 3 Ketone yield and purity are the highest, and PMI is the lowest; therefore, the reaction conditions and raw material consumption of embodiment 3 are the best.
结合实施例3与对比例1、2,可以看出,对比例1与对比例2的反应条件均超出了本申请的保护范围,制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率与纯度均低于实施例3,PMI均高于实施例3,证明,对比例1、2的反应条件不合适本申请。In conjunction with Example 3 and Comparative Examples 1 and 2, it can be seen that the reaction conditions of Comparative Example 1 and Comparative Example 2 have exceeded the protection scope of the present application, and the prepared N-tert-butoxycarbonyl-4-dimethylaminopiper Pyridone yield and purity are all lower than Example 3, and PMI is higher than Example 3, which proves that the reaction conditions of Comparative Examples 1 and 2 are not suitable for the present application.
结合实施例3和对比例3、4,可以看出,对比例3与对比例4的反应原料配比均超出了本申请的保护范围,制得的N-叔丁氧羰基-4-二甲氨基哌啶酮收率与纯度均低于实施例3,PMI均高于实施例3,证明,对比例3、4的反应原料用量不合适本申请。In conjunction with Example 3 and Comparative Examples 3 and 4, it can be seen that the ratio of the raw materials of Comparative Example 3 and Comparative Example 4 has exceeded the protection scope of the present application, and the prepared N-tert-butoxycarbonyl-4-dimethyl Aminopiperidone yield and purity are lower than that of Example 3, and PMI is higher than that of Example 3, which proves that the amount of reaction raw materials in Comparative Examples 3 and 4 is not suitable for this application.
本具体实施例仅仅是对本申请的解释,其并不是对本申请的限制,本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改,但只要在本申请的权利要求范围内都受到专利法的保护。This specific embodiment is only an explanation of this application, and it is not a limitation of this application. Those skilled in the art can make modifications to this embodiment without creative contribution according to needs after reading this specification, but as long as the rights of this application All claims are protected by patent law.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310130932.7A CN116514703A (en) | 2023-06-06 | 2023-06-06 | Method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310130932.7A CN116514703A (en) | 2023-06-06 | 2023-06-06 | Method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116514703A true CN116514703A (en) | 2023-08-01 |
Family
ID=87396495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310130932.7A Pending CN116514703A (en) | 2023-06-06 | 2023-06-06 | Method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116514703A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101531628A (en) * | 2009-04-17 | 2009-09-16 | 大连凯飞精细化工有限公司 | Synthesis method of 4-dimethylamino piperidine hydrochloride |
| WO2017016463A1 (en) * | 2015-07-24 | 2017-02-02 | 上海海雁医药科技有限公司 | Egfr inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof |
| CN115010651A (en) * | 2022-05-11 | 2022-09-06 | 合肥立方制药股份有限公司 | Fixed bed synthesis method of N- (4-fluorobenzylamino) -1-methylpiperidine |
| US20220281840A1 (en) * | 2022-05-09 | 2022-09-08 | Fudan University | Method for continuously preparing n,n-bis(2,2,6,6-tetramethyl-4-piperidyl)-1,6-hexamethylenediamine |
-
2023
- 2023-06-06 CN CN202310130932.7A patent/CN116514703A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101531628A (en) * | 2009-04-17 | 2009-09-16 | 大连凯飞精细化工有限公司 | Synthesis method of 4-dimethylamino piperidine hydrochloride |
| WO2017016463A1 (en) * | 2015-07-24 | 2017-02-02 | 上海海雁医药科技有限公司 | Egfr inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof |
| US20220281840A1 (en) * | 2022-05-09 | 2022-09-08 | Fudan University | Method for continuously preparing n,n-bis(2,2,6,6-tetramethyl-4-piperidyl)-1,6-hexamethylenediamine |
| CN115010651A (en) * | 2022-05-11 | 2022-09-06 | 合肥立方制药股份有限公司 | Fixed bed synthesis method of N- (4-fluorobenzylamino) -1-methylpiperidine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113402395B (en) | Method for continuously and efficiently synthesizing m-phenylenediamine based on fixed bed microreactor | |
| KR100612922B1 (en) | A process for producing 4-aminodiphenylamine | |
| CN113429295B (en) | Method for preparing m-phenylenediamine by continuous catalytic hydrogenation based on fixed bed microreactor | |
| CN105858627B (en) | The recovery method of benzene homologues nitrating wasting acid | |
| CN108126748B (en) | Alkaline monolithic catalyst with regular pores and preparation method and use thereof | |
| CN104028289B (en) | The method of chloro aminobenzen is prepared in titanium carbide loaded with nano metallic catalyst and reduction thereof | |
| CN103804242B (en) | A kind of shortening prepares the method for m-sulfanilic acid | |
| CN102060714A (en) | Method for preparing 4-aminodiphenylamine | |
| WO2023098203A1 (en) | Production method for 4,4'-diaminodiphenyl ether | |
| CN111253218A (en) | Synthesis method and device of 2,3, 5-trimethylhydroquinone | |
| WO2024021969A1 (en) | Method for controlling aniline impurities that are difficult to treat in waste brine in dam production process | |
| CN116554041A (en) | Method for preparing diaminodiphenyl ether by continuous catalytic hydrogenation based on trickle bed reactor | |
| CN110627650A (en) | A device for continuously synthesizing benzylamines by heterogeneous hydrogenation in a microreactor | |
| CN105037204A (en) | Zero-emission production process of N-cyanoethylaniline | |
| CN116514703A (en) | Method for reductive amination of N-tert-butoxycarbonyl-4-piperidone and N-tert-butoxycarbonyl-4-dimethylaminopiperidone | |
| CN106543017A (en) | A kind of preparation method of 4 aminocyclohexyl acetic acid | |
| CN102010340A (en) | Method of catalytic preparation of 4-aminodiphenylamine by Ni-B amorphous alloy-loaded catalyst | |
| CN105646261B (en) | A kind of method for preparing totokaine | |
| CN101863778B (en) | A kind of production method of 4-aminodiphenylamine | |
| CN102942485B (en) | Method for m-dinitrobenzene refinement and effective byproduct utilization | |
| CN107400046B (en) | Process method for preparing methyl isobutyl ketone by acetone liquid phase one-step method | |
| CN115197048B (en) | A kind of preparation method of hydrogenated bisphenol A | |
| CN108516939A (en) | A kind of preparation method of high anti-body 4,4 '-diamino-dicyclohexyl methane of content | |
| CN108031469A (en) | Charcoal-palladium carbon catalyst mixture and preparation method thereof | |
| CN115448868B (en) | Method for strengthening catalytic hydrogenation reaction of nitro compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |